Aquestive Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AQST for the last quarter is 13.21 M USD, and it's 1.57% higher compared to the previous quarter. The net income of Q4 23 is -8.11 M USD.